GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 372 filers reported holding GLOBUS MED INC in Q1 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $71,962 | +2.9% | 1,449,387 | +23.4% | 2.34% | -7.7% |
Q2 2023 | $69,908 | +7.5% | 1,174,135 | +2.2% | 2.54% | +5.5% |
Q1 2023 | $65,050 | +8.1% | 1,148,480 | +41.8% | 2.40% | -6.7% |
Q4 2022 | $60,155 | -99.9% | 809,945 | -4.9% | 2.58% | +6.9% |
Q3 2022 | $50,742,000 | +2.0% | 851,800 | -3.9% | 2.41% | +15.9% |
Q2 2022 | $49,736,000 | -19.7% | 885,922 | +5.5% | 2.08% | -6.3% |
Q1 2022 | $61,971,000 | -7.7% | 839,948 | -9.7% | 2.22% | +12.2% |
Q4 2021 | $67,136,000 | -7.5% | 929,856 | -1.8% | 1.98% | -10.0% |
Q3 2021 | $72,559,000 | -18.2% | 946,997 | -17.2% | 2.20% | -9.7% |
Q2 2021 | $88,717,000 | -2.4% | 1,144,296 | -22.4% | 2.44% | +22.6% |
Q1 2021 | $90,945,000 | -11.3% | 1,474,699 | -6.2% | 1.99% | -15.5% |
Q4 2020 | $102,546,000 | +30.9% | 1,572,303 | -0.6% | 2.35% | +3.5% |
Q3 2020 | $78,358,000 | +3.1% | 1,582,359 | -0.6% | 2.27% | +2.1% |
Q2 2020 | $75,967,000 | +13.0% | 1,592,264 | +0.7% | 2.23% | -7.4% |
Q1 2020 | $67,235,000 | -22.1% | 1,580,884 | +7.9% | 2.40% | +3.2% |
Q4 2019 | $86,277,000 | +10.4% | 1,465,295 | -4.2% | 2.33% | +21.5% |
Q3 2019 | $78,159,000 | +25.1% | 1,528,936 | +3.5% | 1.92% | +6.1% |
Q2 2019 | $62,464,000 | -5.6% | 1,476,695 | +10.3% | 1.81% | -13.8% |
Q1 2019 | $66,167,000 | +21.7% | 1,339,134 | +6.6% | 2.10% | +9.3% |
Q4 2018 | $54,378,000 | -22.4% | 1,256,429 | +1.8% | 1.92% | -3.5% |
Q3 2018 | $70,078,000 | +10.1% | 1,234,636 | -2.1% | 1.99% | +7.4% |
Q2 2018 | $63,662,000 | -7.8% | 1,261,632 | -9.0% | 1.85% | -11.6% |
Q1 2018 | $69,043,000 | +10.7% | 1,385,850 | -8.7% | 2.09% | +3.0% |
Q4 2017 | $62,360,000 | +13.9% | 1,517,266 | -17.6% | 2.03% | +3.4% |
Q3 2017 | $54,753,000 | -16.4% | 1,842,301 | -6.8% | 1.97% | -17.2% |
Q2 2017 | $65,513,000 | +12.2% | 1,976,260 | +0.2% | 2.37% | +8.6% |
Q1 2017 | $58,399,000 | +9.6% | 1,971,620 | -8.2% | 2.19% | +2.2% |
Q4 2016 | $53,265,000 | +7.9% | 2,146,910 | -1.9% | 2.14% | +1.9% |
Q3 2016 | $49,375,000 | -1.4% | 2,187,650 | +4.1% | 2.10% | -8.4% |
Q2 2016 | $50,091,000 | -1.5% | 2,102,030 | -1.8% | 2.29% | -0.8% |
Q1 2016 | $50,848,000 | -10.3% | 2,140,953 | +5.1% | 2.31% | -17.5% |
Q4 2015 | $56,691,000 | +39.0% | 2,037,768 | +3.3% | 2.80% | +37.3% |
Q3 2015 | $40,773,000 | -12.2% | 1,973,526 | +9.1% | 2.04% | -7.2% |
Q2 2015 | $46,423,000 | +3.1% | 1,808,456 | +1.4% | 2.20% | +7.4% |
Q1 2015 | $45,022,000 | +27.0% | 1,783,746 | +19.6% | 2.05% | +19.4% |
Q4 2014 | $35,438,000 | +48.6% | 1,490,857 | +23.0% | 1.71% | +43.7% |
Q3 2014 | $23,848,000 | – | 1,212,395 | – | 1.19% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 589,100 | $45,137,000 | 24.71% |
Sterling Investment Advisors, Ltd. | 188,123 | $14,414,000 | 4.29% |
Godshalk Welsh Capital Management, Inc. | 73,748 | $5,651,000 | 3.52% |
Pembroke Management, LTD | 601,447 | $46,083,000 | 3.47% |
Integral Health Asset Management, LLC | 150,000 | $11,493,000 | 3.30% |
XXEC, Inc. | 51,925 | $3,978,000 | 3.03% |
PARADIGM CAPITAL MANAGEMENT INC/NY | 615,000 | $47,122,000 | 2.42% |
Van Berkom & Associates Inc. | 946,997 | $72,559,000 | 2.20% |
RTW INVESTMENTS, LP | 1,670,811 | $128,018,000 | 1.93% |
Sivik Global Healthcare LLC | 95,000 | $7,279,000 | 1.74% |